85
Participants
Start Date
April 10, 2018
Primary Completion Date
January 22, 2024
Study Completion Date
March 30, 2024
Standard Care
Calcium channel blocker (CCB, amlodipine), angiotensin II receptor blocker (ARB, losartan), and other antihypertensive drugs will be used to reduce 24-hour SBP ≤ 130 mmHg.
Intensive Treatment
Calcium channel blocker (CCB, amlodipine), angiotensin II receptor blocker (ARB, losartan), and other antihypertensive drugs will be used to reduce 24-hour SBP ≤ 120 mmHg.
UT Southwestern Medical Center, Dallas
Texas Health Resources
OTHER
Michigan State University
OTHER
National Institute on Aging (NIA)
NIH
University of Texas Southwestern Medical Center
OTHER